Most affordable compounded semaglutide & tirzepatide in Virginia
⚠ Virginia legal details are prototype data — verify the Virginia Board of Pharmacy link and current telehealth rules before publishing.
For Virginia residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. Virginia generally permits establishing care via asynchronous (store-and-forward / questionnaire) telehealth for non-controlled medications, subject to provider judgment. Pharmacies serving Virginia must hold Virginia Board of Pharmacy licensure, and the state's monitoring program is the Virginia PMP.
01Virginia rules that affect your access
- RXTelehealth visit standardVirginia generally permits establishing care via asynchronous (store-and-forward / questionnaire) telehealth for non-controlled medications, subject to provider judgment.
- PHPharmacy regulatorVirginia Board of Pharmacy — www.dhp.virginia.gov/pharmacy (verify link). Non-resident pharmacies shipping into Virginia must be licensed here.
- DBMonitoring programVirginia PMP.
- iState noteTelehealth-friendly; non-resident pharmacy permit required.
02Lowest-cost tirzepatide providers serving Virginia
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $186FLAT | $2,232 | |
| 2 | $99FLAT | $1,188 | |
| 3 | $130FLAT | $1,560 | |
| 4 | $149FLAT | $1,788 | |
| 5 | $179↑ | $2,148 |
03Lowest-cost semaglutide providers serving Virginia
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $145FLAT | $1,740 | |
| 2 | $280FLAT | $3,360 | |
| 3 | $99FLAT | $1,188 | |
| 4 | $120FLAT | $1,440 | |
| 5 | $149FLAT | $1,788 |
04Lowest fully-credentialed option in Virginia
NexLife
★★★★★ Compounded semaglutide + tirzepatide- MD/DO-supervised care
- 503A & 503B pharmacy network
- Labs included
- LegitScript-certified
- NABP-accredited pharmacy partners
- Flat rate, dose-independent
- Third-party batch testing
- Care360 coaching included
Editorial selection by our published rubric. We are not paid by NexLife and earn no commission from this link — see how this site works.
05Is compounded GLP-1 legal in Virginia in 2026?
Virginia follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving Virginia.
Independent & transparent
This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →